Navigation Links
Oxford Finance Corporation Sponsors 2010 Mid-Atlantic Bio
Date:10/5/2010

ALEXANDRIA, Va., Oct. 5 /PRNewswire/ -- Oxford Finance Corporation (Oxford), a subsidiary of Sumitomo Corporation, today announced that it is a sponsor of 2010 Mid-Atlantic Bio, which takes place October 27-29 in Bethesda, Maryland. Oxford is participating as a Life Sciences Investor Leader sponsor, and, in addition, its executives served on the committee that selects the presenting companies at the conference.

Mid-Atlantic Bio brings together industry leaders, government representatives, researchers, investors and professional services firms from around the world to promote networking, business expansion and technical-knowledge sharing.

"Oxford has proudly sponsored Mid-Atlantic Bio since its inception in 2006," said J. Alden Philbrick, president and chief executive officer of Oxford Finance Corporation. "Although this conference draws prominent leaders from all over the country, it has been especially valuable as a forum for information sharing and stimulating growth in the Mid-Atlantic region."

About Oxford Finance Corporation

A subsidiary of Sumitomo Corporation, Oxford is a specialty finance firm providing senior secured loans to public and private life science and healthcare services companies worldwide. For over 20 years, Oxford has delivered flexible financing solutions to its clients, enabling these companies to maximize their equity by leveraging their assets. In recent years, Oxford has originated over $1.5 billion in loans, with lines of credit ranging from $500 thousand to $40 million. Oxford is headquartered in Alexandria, Virginia, with additional offices in California, Massachusetts and North Carolina. For more information visit www.oxfordfinance.com.

About Mid-Atlantic Bio

The Mid-Atlantic Bio Conference is co-hosted by the Tech Council of Maryland, the Mid-Atlantic Venture Association, and the Virginia Biotechnology Association. Mid-Atlantic Bio benefits from broad regional support from the investor and greater business communities, academic institutions, government agencies, and partnering regional associations. Mid-Atlantic Bio is the only globally focused, yet regionally based, event to combine components of a bioscience industry convention with an investor conference. More than 800 executives will gather to promote networking, business expansion, and technical-knowledge sharing. Home to industry-critical regulatory and research agencies; federal policymaking; and business and scientific centers of excellence, the Mid-Atlantic is a unique center for the global bioscience industry.


'/>"/>
SOURCE Oxford Finance Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Oxford Resource Partners, LP and Mendel Biotechnology, Inc. Announce a Miscanthus Biomass Pilot Project in Ohio
2. Oxford Finance Corporation Hires Dr. Killu Sanborn to Support Life Science Business Development in Western North America
3. ALS Therapy Development Institute and Oxford BioMedica Begin Second Phase of Collaboration to Develop Gene Therapies for Amyotrophic Lateral Sclerosis
4. Oxford BioTherapeutics Appoints Michael Moore as Chairman
5. Oxford Performance Materials Introduces OXPEKK PermettaTM High Performance Polymer Films
6. TED Conferences Announces 25 TED Fellows for TEDGlobal in Oxford
7. The Court Supports Bavarian Nordics Decision to Start Patent Infringement Case Against Oxford BioMedica
8. Bavarian Nordics Case Against Oxford BioMedica
9. New Dual Wavelength X-ray Diffractometer From Oxford Diffraction, Now a Part of Varian, Inc., Allows Increased Throughput for Challenging Single Crystal Analyses
10. Adeona Appoints Julie A. Caudill, B.B.A., Vice President of Finance and Corporate Controller
11. Merrimack Pharmaceuticals Promotes William Sullivan to Vice President of Finance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 8, 2016 Oxford Gene Technology ... SureSeq™ NGS panel range with the launch of the SureSeq ... study of variants in familial hypercholesterolemia (FH). The panel delivers ... on a single small panel and allows customisation by ,mix ... all exons for LDLR , P C ...
(Date:12/8/2016)... ... December 08, 2016 , ... Microbial genomics leader, ... uBiome is one of just six company finalists in the Health & Medicine ... uBiome, companies nominated as finalists in this year’s awards include Google, SpaceX, Oculus, ...
(Date:12/8/2016)... 8, 2016  HedgePath Pharmaceuticals, Inc. (OTCQX: HPPI), ... and plans to commercialize innovative therapeutics for patients ... stock were approved for trading on the OTCQX ... the OTCQX, effective today, under the ticker symbol ... market, companies must meet high financial standards, follow ...
(Date:12/8/2016)... 8, 2016   Biocept, Inc . (NASDAQ: ... of clinically actionable liquid biopsy tests to improve ... data featuring its Target Selector™ Circulating Tumor Cell ... the detection of actionable biomarkers in patients with ... by Sara Cannon Research Institute (SCRI), the research ...
Breaking Biology Technology:
(Date:12/5/2016)... -- The Office of Justice Programs, National Institute of ... or Replace Medico Legal Autopsies?" on NIJ.gov.  The ... forensic autopsies with postmortem X-ray computed tomography, commonly ... to recommendations made by The National Academy of ... a potential component of medicolegal death investigations. NIJ,s ...
(Date:12/2/2016)... 2016   SoftServe , a global digital ... an electrocardiogram (ECG) biosensor analysis system for continuous ... asset. The smart system ensures device-to-device communication between ... and mobile devices to easily ,recognize, and monitor ... vehicle technology advances, so too must the security ...
(Date:11/30/2016)... , Nov. 30, 2016  higi SH llc ... partnership initiative targeting national brands, industry thought-leaders and ... their respective audiences for taking steps to live ... inception in 2012, higi has built the largest ... over 38 million people who have conducted over ...
Breaking Biology News(10 mins):